keyword
https://read.qxmd.com/read/38525051/dapagliflozin-pretreatment-prevents-cardiac-electrophysiological-changes-in-a-diet-and-streptozotocin-induction-of-type-2-diabetes-in-rats-a-potential-new-first-line
#21
JOURNAL ARTICLE
Prabhjot Kaur Juttla, Boniface Mwangi Chege, Peter Waweru Mwangi, Frederick Bukachi
PURPOSE: Dapagliflozin exerts cardioprotective effects in Type 2 Diabetes Mellitus (T2DM). However, whether these effects prevent electrocardiographic changes associated with T2DM altogether remain unknown. Our aim was to investigate the prophylactic effect of dapagliflozin pretreatment on the rat ECG using a high-fat, high-fructose (HFHf) diet and a low dose streptozotocin (STZ) model of T2DM. METHODS: Twenty-five (25) rats were randomized into five (5) groups: normal control receiving a normal diet while the other groups received an 8-week HFHf and 40mg/kg STZ on day 42, and either: saline for the diabetic control (1 mg/kg/d), low dose (1...
2024: Journal of Experimental Pharmacology
https://read.qxmd.com/read/38517762/metformin-use-in-type-2-diabetics-and-delirium-after-noncardiac-surgery-a-retrospective-cohort-analysis
#22
JOURNAL ARTICLE
Stephania Paredes, Ayoub Harb, Julian Rössler, Maede Zookaei Nikoo, Kurt Ruetzler, Alparslan Turan, Xuan Pu, Daniel I Sessler
INTRODUCTION: The cause of postoperative delirium is unknown, but it is thought to result at least in part from inflammation. Metformin, besides its hypoglycemic properties, demonstrates anti-inflammatory effects systemically and in the brain. We tested the primary hypothesis that chronic metformin use in adults with type 2 diabetes is associated with less delirium during the first 5 days after major noncardiac surgery. Secondary outcomes were a composite of serious complications (myocardial infarction, cardiac arrest, stage 2-3 acute kidney injury [AKI], and mortality) and time to discharge alive...
March 22, 2024: Anesthesia and Analgesia
https://read.qxmd.com/read/38517045/drug-target-mendelian-randomization-revealed-a-significant-association-of-genetically-proxied-metformin-effects-with-increased-prostate-cancer-risk
#23
JOURNAL ARTICLE
Xiaohui Sun, Jie Ping, Xingyi Guo, Jirong Long, Qiuyin Cai, Xiao-Ou Shu, Xiang Shu
The association between metformin use and risk of prostate cancer remains controversial, while data from randomized trials is lacking. We aim to evaluate the association of genetically proxied metformin effects with prostate cancer risk using a drug-target Mendelian randomization (MR) approach. Summary statistics for prostate cancer were obtained from the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome Consortium (79,148 cases and 61,106 controls). Cis-expression quantitative trait loci (cis-eQTL) variants in the gene targets of metformin were identified in the GTEx project and eQTLGen consortium...
March 22, 2024: Molecular Carcinogenesis
https://read.qxmd.com/read/38502874/prevalence-of-distal-symmetrical-polyneuropathy-by-diabetes-prevention-program-treatment-group-diabetes-status-duration-of-diabetes-and-cumulative-glycemic-exposure
#24
JOURNAL ARTICLE
Christine G Lee, Adam Ciarleglio, Sharon L Edelstein, Jill P Crandall, Dana Dabelea, Ronald B Goldberg, Steven E Kahn, William C Knowler, Maxwell T Ma, Neil H White, William H Herman
OBJECTIVE: To assess associations between distal symmetric polyneuropathy (DSPN) and Diabetes Prevention Program (DPP) treatment groups, diabetes status or duration, and cumulative glycemic exposure approximately 21 years after DPP randomization. RESEARCH DESIGN AND METHODS: In the DPP, 3,234 adults ≥25 years old at high risk for diabetes were randomized to an intensive lifestyle (ILS), metformin, or placebo intervention to prevent diabetes. After the DPP ended, 2,779 joined the Diabetes Prevention Program Outcomes Study (DPPOS)...
May 1, 2024: Diabetes Care
https://read.qxmd.com/read/38497512/the-association-between-metformin-use-and-new-onset-icd-coding-of-geographic-atrophy
#25
JOURNAL ARTICLE
John Moir, Max J Hyman, Reem Gonnah, Andrea Flores, Seenu M Hariprasad, Dimitra Skondra
PURPOSE: Metformin has been suggested to protect against the development of age-related macular degeneration (AMD) in multiple observational studies. However, the association between metformin and geographic atrophy (GA), a debilitating subtype of AMD, has not been analyzed. METHODS: We conducted a case-control study of patients ages 60 years and older with new-onset International Classification of Diseases (ICD) coding of GA in the Merative MarketScan Commercial and Medicare Databases between 2017 and 2021...
March 5, 2024: Investigative Ophthalmology & Visual Science
https://read.qxmd.com/read/38494571/evaluating-the-safety-and-efficacy-of-sodium-glucose-co-transporter%C3%A2-2-inhibitors-in-subjects-with-prediabetes-a-protocol-for-a-randomized-controlled-trial
#26
JOURNAL ARTICLE
Xiaxuan Zhu, Li Xia, Deshan Yin, Jin Yang, Rui Wei
INTRODUCTION: Prediabetes is a state of subclinical glycemic impairment, bridging normal glucose tolerance and diabetes. Globally, over 30% of individuals exhibit prediabetic conditions, with a significant proportion progressing to diabetes. Prediabetes augments risks of various diseases including cardiovascular and kidney disease. While interventions like lifestyle changes have shown promise in diabetes prevention, their long-term sustainability is challenging. Alternative pharmacological treatments, such as acarbose and metformin, have demonstrated efficacy in certain populations...
March 18, 2024: Diabetes Therapy: Research, Treatment and Education of Diabetes and related Disorders
https://read.qxmd.com/read/38491813/cardiovascular-anti-inflammatory-drugs-repurposed-for-treating-or-preventing-cancer-a-systematic-review-and-meta-analysis-of-randomized-trials
#27
JOURNAL ARTICLE
David J Benjamin, Alyson Haslam, Vinay Prasad
BACKGROUND: Due to encouraging pre-clinical data and supportive observational studies, there has been growing interest in applying cardiovascular drugs (including aspirin, angiotensin-converting enzyme [ACE] inhibitors, statins, and metformin) approved to treat diseases such as hypertension, hyperlipidemia, and diabetes mellitus to the field of oncology. Moreover, given growing costs with cancer care, these medications have offered a potentially more affordable avenue to treat or prevent recurrence of cancer...
March 2024: Cancer Medicine
https://read.qxmd.com/read/38486821/synergistic-effect-of-metformin-and-vitamin-d-3-on-osteogenic-differentiation-of-human-adipose-tissue-derived-mesenchymal-stem-cells-under-high-d-glucose-conditions
#28
JOURNAL ARTICLE
Nhi Nguyen-Yen Ha, Thi Kim Tan Huynh, Ngoc Uyen Phuong Phan, Thi-Hiep Nguyen, Long Binh Vong, Nhu-Thuy Trinh
INTRODUCTION: Vitamin D3 plays a vital role in bone health, with low levels of vitamin D3 being related to skeletal fragility, fractures, and metabolic disorders such as diabetes. Metformin is known as an antihyperglycemic agent for regulating blood sugar. A correlation between diabetes mellitus and osteoporosis is attracting considerable interest, and research to find the prevention and treatment is gradually being studied. In this study, we investigated the effect of metformin and vitamin D3 on osteogenic differentiation of human adipose tissue-derived mesenchymal stem cells (AT-MSCs) under high d-glucose concentrations and optimized by combining vitamin D3 and metformin in the process...
March 2024: Regenerative Therapy
https://read.qxmd.com/read/38477839/clinical-outcomes-with-metformin-use-in-diabetic-patients-with-compensated-cirrhosis-a-systematic-review-and-meta-analysis
#29
JOURNAL ARTICLE
Spyros Peppas, Stavros Doumas, Advait Suvarnakar, Jiling Chou, Ayah Arafat, Akram I Ahmad, James H Lewis
BACKGROUND: Previous studies have demonstrated a beneficial effect of metformin in patients with cirrhosis, but no improvement in liver histology. AIM: To investigate the impact of metformin on mortality and hepatic decompensation in people with diabetes with compensated cirrhosis. METHODS: Medline, Embase and Cochrane databases were searched from inception to February 2023 for studies reporting results regarding the impact of metformin on all-cause mortality and hepatic decompensation in people with diabetes with compensated cirrhosis...
March 11, 2024: European Journal of Gastroenterology & Hepatology
https://read.qxmd.com/read/38465107/factors-influencing-the-choice-of-glucose-lowering-medications-among-physicians-treating-patients-with-type-2-diabetes
#30
JOURNAL ARTICLE
Mohammed E AlSofiani, Danah Z AlHalees, Joud A Aljebreen, Joud A Abu Dahesh, Ghada S Bamogaddam, Ghaida M AlBraithen, Anwar Jammah
Background The factors considered by physicians when prescribing a glucose-lowering agent to patients with type 2 diabetes (T2D) in real-world settings are not necessarily consistent with those recommended by clinical practice guidelines. Here, we identify the major factors that drive physicians' selection of glucose-lowering agents in the real world and how these factors may differ by physician's specialty.  Methods A web-based survey was conducted among 135 physicians who manage patients with T2D in Saudi Arabia...
February 2024: Curēus
https://read.qxmd.com/read/38451994/antidiabetic-drug-administration-prevents-bone-mineral-density-loss-evidence-from-a-two-sample-mendelian-randomization-study
#31
JOURNAL ARTICLE
Mingzhu Chen, Shuisen Lin, Wanqiong Chen, Xiaoqiang Chen
The aim of this study was to investigate the effect of common antidiabetic drugs on BMD by two-sample Mendelian randomization (MR). The single nucleotide polymorphisms that were strongly associated with insulin, metformin, rosiglitazone and gliclazide were extracted as instrumental variables (IVs) for MR analysis. The inverse variance weighted (IVW) method was used as the primary MR method to assess the causal effect of antidiabetic drugs on BMD, and other MR methods, including Weighted median, MR Egger and Weighted mode, were used for complementary analysis...
2024: PloS One
https://read.qxmd.com/read/38435926/knowledge-attitude-and-practice-of-adult-diabetics-regarding-diabetic-foot-ulcers-a-cross-sectional-study-in-saudi-arabia
#32
JOURNAL ARTICLE
Safa H Alkalash, Faisal H Alnashri, Amnah I Alnashri, Khadijah A Alghubayshi, Manar A Alsumaydi, Wael S Alzubaidi, Sarah M Alshuqayfi, Fuad M Alkudaysi, Naeem F Qusty
Background Diabetic foot ulcers (DFUs) are one of the most common and fatal complications of diabetic patients with uncontrolled diabetes mellitus (DM) that may end with their feet amputation. These complications can be prevented through the adherence of diabetic patients to their diabetes management plan and by educating them about risk factors, complications of diabetic foot, and proper foot care. To develop effective health education programs to educate diabetic patients and caregivers regarding diabetic foot and its effective care, we should first identify gaps in patients' knowledge and perception of diabetic foot and evaluate their practice of foot care...
January 2024: Curēus
https://read.qxmd.com/read/38408173/association-of-metformin-use-with-risk-of-newly-onset-neovascular-age-related-macular-degeneration-development
#33
JOURNAL ARTICLE
Saira Khanna, Lincoln Shaw, Max J Hyman, Jason Zhang, Seenu Hariprasad, Jackie Soo, Andrea Flores, Dimitra Skondra
PURPOSE: To investigate if metformin use reduces the odds of developing new neovascular AMD (nAMD). METHODS: This is a case-control study of 86,930 subjects with new diagnoses of nAMD and 86,918 matched controls using the Merative™ Marketscan® Research Databases. Subjects were analyzed using multivariable conditional logistic regression to identify the risks of various exposures on developing nAMD. A subgroup analysis of 22,117 diabetic cases and 21,616 diabetic controls was also performed...
October 30, 2023: Retina
https://read.qxmd.com/read/38405837/metformin-reduces-the-clonal-fitness-of-dnmt3ar878h-hematopoietic-stem-and-progenitor-cells-by-reversing-their-aberrant-metabolic-and-epigenetic-state
#34
Steven Chan, Mohsen Hosseini, Veronique Voisin, Ali Chegini, Angelica Varesi, Severine Cathelin, Dhanoop Manikoth Ayyathan, Alex Liu, Yitong Yang, Vivian Wang, Abdula Maher, Eric Grignano, Julie Haines, Angelo D'Alessandro, Kira Young, Yiyan Wu, Martina Fiumara, Samuele Ferrari, Luigi Naldini, Federico Gaiti, Shraddha Pai, Aaron Schimmer, Gary Bader, John Dick, Stephanie Z Xie, Jennifer Trowbridge
Clonal hematopoiesis (CH) arises when a hematopoietic stem cell (HSC) acquires a mutation that confers a competitive advantage over wild-type (WT) HSCs, resulting in its clonal expansion. Individuals with CH are at an increased risk of developing hematologic neoplasms and a range of age-related inflammatory illnesses1-3. Therapeutic interventions that suppress the expansion of mutant HSCs have the potential to prevent these CH-related illnesses; however, such interventions have not yet been identified. The most common CH driver mutations are in the DNA methyltransferase 3 alpha (DNMT3A) gene with arginine 882 (R882) being a mutation hotspot...
February 6, 2024: Research Square
https://read.qxmd.com/read/38396657/risks-and-benefits-of-sglt-2-inhibitors-for-type-1-diabetes-patients-using-automated-insulin-delivery-systems-a-literature-review
#35
REVIEW
Viviana Elian, Violeta Popovici, Oana Karampelas, Gratiela Gradisteanu Pircalabioru, Gabriela Radulian, Madalina Musat
The primary treatment for autoimmune Diabetes Mellitus (Type 1 Diabetes Mellitus-T1DM) is insulin therapy. Unfortunately, a multitude of clinical cases has demonstrated that the use of insulin as a sole therapeutic intervention fails to address all issues comprehensively. Therefore, non-insulin adjunct treatment has been investigated and shown successful results in clinical trials. Various hypoglycemia-inducing drugs such as Metformin, glucagon-like peptide 1 (GLP-1) receptor agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, amylin analogs, and Sodium-Glucose Cotransporters 2 (SGLT-2) inhibitors, developed good outcomes in patients with T1DM...
February 6, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38391178/-b-longum-ckd1-enhances-the-efficacy-of-anti-diabetic-medicines-through-upregulation-of-il-22-response-in-type-2-diabetic-mice
#36
JOURNAL ARTICLE
Won Jun Kim, Bum Ju Kil, Chaewon Lee, Tae Young Kim, Goeun Han, Yukyung Choi, Kyunghwan Kim, Chang Hun Shin, Seung-Young Park, Heebal Kim, Myunghoo Kim, Chul Sung Huh
The gut microbiota plays a pivotal role in metabolic disorders, notably type 2 diabetes mellitus (T2DM). In this study, we investigated the synergistic potential of combining the effects of Bifidobacterium longum NBM7-1 (CKD1) with anti-diabetic medicines, LobeglitazoneⓇ (LO), SitagliptinⓇ (SI), and MetforminⓇ (Met), to alleviate hyperglycemia in a diabetic mouse model. CKD1 effectively mitigated insulin resistance, hepatic steatosis, and enhanced pancreatic β-cell function, as well as fortifying gut-tight junction integrity...
2024: Gut Microbes
https://read.qxmd.com/read/38369526/naringin-from-sweet-orange-peel-improves-testicular-function-in-high-fat-diet-induced-diabetic-rats-by-modulating-xanthine-oxidase-uric-acid-signaling-and-maintaining-redox-balance
#37
JOURNAL ARTICLE
Kazeem Bidemi Okesina, Adeyemi Fatai Odetayo, Wale Johnson Adeyemi, Ayodeji Johnson Ajibare, Akeem Ayodeji Okesina, Luqman Aribidesi Olayaki
BACKGROUND: Type 2 diabetes mellitus (T2DM) is a metabolic disorder affecting many organs, including the testis. Naringin from orange peel extract (OPE) is a flavanone with fertility-enhancing properties. Hence, this study was designed to establish the effect of naringin on T2DM-induced testicular dysfunction. Thirty male (30) Wistar rats were randomized into five groups control, diabetes, diabetes + naringin, diabetes + OPE, and diabetes + metformin...
February 18, 2024: Laboratory Animal Research
https://read.qxmd.com/read/38358644/anticarcinogenic-effects-of-gold-nanoparticles-and-metformin-against-mcf-7-and-a549-cells
#38
JOURNAL ARTICLE
Ali Yeşildağ, Halime Topal Kızıloğlu, Ebubekir Dirican, Elif Erbaş, Volkan Gelen, Adem Kara
Metformin is commonly prescribed to people with diabetes. Metformin has been shown in previous studies to be able to prevent the growth of cancer cells. This study aims to investigate the effects of metformin and gold nanoparticles in MCF7 breast cancer and A549 lung cell lines. The effects of metformin and gold nanoparticles on MCF7 breast cancer and A549 lung cells were determined on cells grown in 24 h cell culture. MCF-7 and A549 cells were incubated for 24 h with the treatment of escalating molar concentrations of ifosfamide...
February 15, 2024: Biological Trace Element Research
https://read.qxmd.com/read/38346816/effects-of-metformin-on-glucose-metabolism-and-mitochondrial-function-in-patients-with-obstructive-sleep-apnea-a-pilot-randomized-trial
#39
RANDOMIZED CONTROLLED TRIAL
Elizabeth R M Zunica, Elizabeth C Heintz, Wagner S Dantas, R Caitlin Hebert, MaKayla Tanksley, Robbie A Beyl, Edward C Mader, John P Kirwan, Christopher L Axelrod, Prachi Singh
Obstructive sleep apnea (OSA) is associated with increased risk for diabetes, and standard treatment with positive airway pressure (PAP) device shows inconsistent effects on glucose metabolism. Metformin is known to treat and prevent diabetes, but its effects on skeletal muscle mitochondrial function are not completely understood. Here, we evaluate the effects of metformin on glucose metabolism and skeletal muscle mitochondrial function in patients with OSA. Sixteen adults with obesity (50.9 ± 6...
February 2024: Physiological Reports
https://read.qxmd.com/read/38330228/machine-learning-identifies-metabolic-dysfunction-associated-steatotic-liver-disease-in-patients-with-diabetes-mellitus
#40
JOURNAL ARTICLE
Katarzyna Nabrdalik, Hanna Kwiendacz, Krzysztof Irlik, Mirela Hendel, Karolina Drożdż, Agata M Wijata, Jakub Nalepa, Oliwia Janota, Wiktoria Wójcik, Janusz Gumprecht, Gregory Y H Lip
BACKGROUND & AIMS: The presence of metabolic dysfunction associated steatotic liver disease (MASLD) in patients with diabetes mellitus (DM) is associated with a high risk of cardiovascular disease, but is often under-diagnosed. The objective is to develop machine learning (ML) models for risk assessment of MASLD occurrence in patients with DM. METHODS: Feature selection determined the discriminative parameters, utilized to classify DM patients as those with and without MASLD...
February 8, 2024: Journal of Clinical Endocrinology and Metabolism
keyword
keyword
99673
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.